Welcome to the Precision Medicine Podcast, where experts come to discuss the problems oncologists, reference labs, and payers face as precision medicine grows, and consider solutions for advancing the quality of patient-centered cancer care.
Precision Medicine is Coming Faster Than You Think: Guests Rob Metcalf and Clynt Taylor
It is fitting that our first guests on Season 3 of the Precision Medicine Podcast are Rob Metcalf, CEO of Concert Genetics and Clynt Taylor, CEO of Trapelo Health who are both innovators in precision medicine technology. What we learn from them in this episode is that after 20 years of hearing about the “promise of precision medicine,” technology has reached a critical point where it can begin to accelerate that progress. Read the full summary, listen and learn more here. (https://www.trapelohealth.com/precision-medicine-technology)
Dr. Luis Raez Discusses the Impact of Precision Medicine in Lung Cancer Treatment
In this episode (http://trapelohealth.com/lung-cancer-precision-medicine), and in honor of lung cancer awareness month we had the opportunity to speak with Dr. Luis Raez, Medical Director and Chief of Hematology Oncology at Memorial Cancer Institute who focuses on treating lung cancer. Hear how the emergence of next-generation sequencing has changed his approach to lung cancer treatment, what notable discoveries in lung cancer have occurred over the last year, and how he sees COVID-19 impacting the treatment of cancer. Tune in to the full episode here (http://trapelohealth.com/lung-cancer-precision-medicine).
Dr. Gabriel Bien-Willner Part 1: Reshaping Reimbursement Policies for Genetic and Genomic Testing
In the first of a two-part podcast, (https://www.trapelohealth.com/reimbursement-for-genetic-testing) Gabriel A. Bien-Willner MD, PhD, FCAP, Medical Director at MolDX, and Chief Medical Officer at Palmetto GBA shares how he has helped implement payer controls and coverage and set policies for affiliated Medicare Administrative Contractors in 28 states.
In the past, payers have had to navigate the growing field of precision medicine without the benefit of expertise, so their only guidance came from the NCCN or consultations with other experts in the field. Today, under his direction, Palmetto GBA is able to base its policies on evidentiary reviews, and he believes this form of evidence-based decision-making should be an industrywide standard.
Breast Cancer Specialist Dr. Mark Moasser Discusses Overcoming Barriers to Clinical Trial Access
Dr. Mark Moasser (https://www.trapelohealth.com/breast-cancer-clinical-trials), a physician-scientist and breast cancer specialist at the University of California, San Francisco discusses his research focus on the HER2 oncogene, the latest trial findings and the importance of improving patient access to clinical trials.
At Trapelo, connecting oncologists with patient-appropriate clinical trials (https://www.trapelohealth.com/for-oncologists) is a major part of our mission, so we were grateful for the opportunity to talk to Dr. Moasser and learn more about his thoughts on this matter. Tune in to the full episode to learn more about his current research and perspective on the future of precision medicine.
Lori Brisbin Explains How Trapelo Helps Keep Texas Oncology Ahead of the Precision Medicine Curve
In this episode, Clynt Taylor, CEO at Trapelo Health, talks with Lori Brisbin, Vice President of Precision Medicine at Texas Oncology, one of the largest practices in the United States. The discussion centers on how this expansive network of oncologists is leveraging the web-based Trapelo™ platform to provide evidence-based decision support to its physicians and bring precision medicine to the forefront of patient care
Robin Toft on the Life Science Industry’s Talent Crisis, Advancement for Women, and Why It’s Critical for CEO’s to Focus on Diversity
On this Precision Medicine Podcast (https://www.trapelohealth.com/precision-medicine-leadership), author and CEO of the Toft Group (a ZRG company), Robin Toft, joins us to discuss her new book, We Can, and share her thoughts on the need for more women and greater diversity in the C-suite and the boardroom within the life science industry. Read the full summary here (https://www.trapelohealth.com/precision-medicine-leadership).
Customer ReviewsSee All
Excellent source of information spanning a wide range of stake holders across the spectrum of precision medicine.
Pretty good but “unempathetic ‘yeahs’”
Generally pretty good content but have listened to multiple podcasts where moderator responds to really deep life and death statements from guests (eg ROS1ders talking about the ends of their lives, women leadership expert talking about under representation) with “yeah...<next question>.” I just want moderator to know that that’s happening and consider finding a more respectful and empathetic way to keep things moving. But keep up the podcast it’s good and needed - maybe could be a bit deeper as audience is expert not intro.
this is a MUST LISTEN !
HIGHLY valuable information and insights for the entire cancer ecosystem -- patient, caregiver, family, friends, et. al. the book is even better!